成骨不全患者全髋关节置换术的长期结局
回顾性分析1969–2018年11例(13髋)成骨不全(OI)患者初次全髋关节置换术(THA),平均随访13年;
要点
- OI患者THA长期翻修率高,20年无翻修生存率仅52%。
- 平均9年时31%髋需翻修,但无术中并发症。
核心结论
- OI患者THA翻修率高、长期生存率低,但功能结局较术前改善。
研究设计与样本
- 回顾性分析本机构1969–2018年全关节登记中OI患者初次THA,共11例(13髋),平均随访13年(范围6–20)。
主要发现
- 4髋(31%)在平均9年(范围5–17)时行翻修手术。
- 20年无组件翻修生存率为52%。
- 13例初次THA术中无并发症发生。
- 1例患者(1髋)死亡,末次随访时13髋植入物状态均已知。
关键数值与推荐
- 无组件翻修生存率20年为52%。
- 翻修率31%(4/13髋),平均翻修时间9年(范围5–17)。
临床怎么用
- OI患者THA需告知高翻修率和低长期生存率,但功能可改善。
- 长期随访中应关注翻修风险,平均9年左右为翻修高发期。
局限性
- 回顾性设计,样本量小(11例13髋),证据等级为Level IV。
- 随访时间范围6–20年,部分患者随访较短。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Osteogenesis imperfecta (OI) comprises a spectrum of disorders that result in bone fragility. This presents unique challenges when performing total joint arthroplasty in patients with OI. The purpose of this study is to determine the survivorship and clinical outcomes of total hip arthroplasty (THA) in patients with OI. METHODS: We retrospectively reviewed our institution's total joint registry from 1969 to 2018 for all primary THAs in patients with a history of OI. There were 11 patients (13 hips) with a mean follow-up of 13 years (range 6-20). Survivorship free of component revision was determined using Kaplan-Meier analysis. Patient-reported clinical outcomes were assessed using Harris Hip Scores. RESULTS: At final follow-up, the status of the implant was known in all 13 hips. One patient (1 hip) was deceased. Four hips (31%) underwent revision surgery at a mean of 9 years (range 5-17). Survivorship free of component revision was 52% at 20 years. Mean Harris Hip Scores at final follow-up were fair (75, 47-97), but significantly improved compared to available preoperative scores (P = .0015). No intraoperative complications occurred during the 13 primary THAs. CONCLUSION: THA in patients with OI is associated with high revision rates and low survivorship at long-term follow-up. Although this is a very challenging patient population, THA provided these patients with improved functional outcomes. To the authors' knowledge, this is the largest series of primary THA in patients with OI reported in the literature and therefore provides surgeons with important data regarding the expected outcomes following THA in this unique patient population. LEVEL OF EVIDENCE: Level IV.
引用
- Carlson SW, Sierra RJ, Trousdale RT, et al. Total Hip Arthroplasty in Patients With Osteogenesis Imperfecta. J Arthroplasty. 2020. PMID: 32359957. doi:10.1016/j.arth.2020.03.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。